Biotech chief lashes hedge fund's patent trolling
September 19, 2015 at 16:13 PM EDT
Hedge fund heavyweight Kyle Bass has placed a big bet in biotech but one CEO is defending his company against the activist's claims.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|